CIK 0001808805
- Non-accelerated filer
- Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981541723
- Phone
- +1 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel acquired 10,000 shares (grant or award)
- 4 Open-market buy CEO, President, and Secretary bought 50,000 shares at $3.96 ($198,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO, President, and Secretary bought 50,000 shares at $3.60 ($179,890)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 8 · 141 filings